Seeking Alpha

More on Monster Beverage (MNST) (previous): Goldman Sachs calls the response from the FDA on the...

More on Monster Beverage (MNST) (previous): Goldman Sachs calls the response from the FDA on the energy drink health concerns relatively "benign" and encouraging for shareholders of the company. The common sense approach by consumers is likely to be moderation and increased oversight by parents - instead of anything resembling a ban or graphic warning labels. MNST +12.5% to $51.50.
From other sites
Comments (2)
  • jean5566
    , contributor
    Comments (71) | Send Message
     
    now on play for coke or pepsi offer .
    27 Nov 2012, 01:33 PM Reply Like
  • Joseph Poma
    , contributor
    Comments (442) | Send Message
     
    Been saying this all along...

     

    http://seekingalpha.co...
    27 Nov 2012, 02:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs